Multidisciplinary treatment of life-threatening hemoptysis and paraplegia of choriocarcinoma with pulmonary, hepatic and spinal metastases: A case report

Table 1 Demography, clinical and laboratory features both in hospital and reference laboratory

Age in yr			40
Gender			Female
City			Sanming, Fujian, China
Dates of enrollment			12/18/2017
Duration of treatment stay in d			361
Symptoms and signs at enrollment
Fever				No
Headache/dizziness				No
Hemoptysis				Yes
Shortness of breath				Yes
Cough				Yes
Nausea/vomiting				No
Lower back pain				Yes
Vaginal bleeding				No
Laboratory results (normal value range)	Day 1 enrollment	Day 2 enrollment			Day 3 enrollment	After one cycle of chemotherapy	After MDT and before discharge
White blood cell count (3.5-9.5 × 109/L)	15.3	10.3			13.8	16.2	17.1
Neutrophil count (1.8-6.3 × 109/L)	14.4	8.4			12.5	12.7	15.2
Platelet count (125-350 × 109/L)	194	138			112	183	38
Hemoglobin (11.5-15.0 g/dL)	10.9	9.1			5.8	9.2	9.3
Total protein (63-82 g/L)	56	47			37	58	65
Albumin (35-50 g/L)	32	29			22	35	34
Aspartate aminotransferase (13-69 U/L)	52	35			37	40	20
Alanine aminotransferase (15-46 U/L)	25	23			34	49	50
Blood urea nitrogen (2.5-6.1 mmol/L)	4.1	4.0			6.8	3.1	2.9
Serum creatinine (46-92 μmol/L)	44	33			48	47	54
β-hCG (< 5 IU/L)	ND	ND			58162	ND	ND

β-HCG: β-Human chorionic gonadotropin; MDT: Multidisciplinary treatment; ND: Not done.